UCLA investigators have developed a new artificial intelligence-based platform that could help scientists identify promising drug combinations to overcome treatment resistance in cancer, the school announced Wednesday. The platform, called MAESTRO and described in Advanced Science, uses large language models, or LLMs, to analyze scientific knowledge about how drugs work and the biological pathways cancer […]
